SETD3
Actin-histidine N-methyltransferase
Also known as: C14orf154, FLJ23027, SETD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86TU7
- Gene
- SETD3
- Ensembl
- ENSG00000183576
- Chromosome
- 14
- Canonical length
- 594 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Enables protein-L-histidine N-tele-methyltransferase activity. Involved in actin modification and peptidyl-histidine methylation. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
594 residues, UniProt reviewed canonical sequence.
>Q86TU7|SETD3
1 MGKKSRVKTQ KSGTGATATV SPKEILNLTS ELLQKCSSPA PGPGKEWEEY VQIRTLVEKI
61 RKKQKGLSVT FDGKREDYFP DLMKWASENG ASVEGFEMVN FKEEGFGLRA TRDIKAEELF
121 LWVPRKLLMT VESAKNSVLG PLYSQDRILQ AMGNIALAFH LLCERASPNS FWQPYIQTLP
181 SEYDTPLYFE EDEVRYLQST QAIHDVFSQY KNTARQYAYF YKVIQTHPHA NKLPLKDSFT
241 YEDYRWAVSS VMTRQNQIPT EDGSRVTLAL IPLWDMCNHT NGLITTGYNL EDDRCECVAL
301 QDFRAGEQIY IFYGTRSNAE FVIHSGFFFD NNSHDRVKIK LGVSKSDRLY AMKAEVLARA
361 GIPTSSVFAL HFTEPPISAQ LLAFLRVFCM TEEELKEHLL GDSAIDRIFT LGNSEFPVSW
421 DNEVKLWTFL EDRASLLLKT YKTTIEEDKS VLKNHDLSVR AKMAIKLRLG EKEILEKAVK
481 SAAVNREYYR QQMEEKAPLP KYEESNLGLL ESSVGDSRLP LVLRNLEEEA GVQDALNIRE
541 AISKAKATEN GLVNGENSIP NGTRSENESL NQESKRAVED AKGSSSDSTA GVKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SETD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 163 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 163 nTPM
- tongue: 110 nTPM
- kidney: 90 nTPM
- testis: 80 nTPM
- epididymis: 79 nTPM
- heart muscle: 74 nTPM
Single-cell type
- late primary spermatocytes: 311 nCPM
- proximal tubule cells: 263 nCPM
- early spermatids: 183 nCPM
- cone photoreceptor cells: 182 nCPM
- late spermatids: 169 nCPM
- neutrophil progenitors: 165 nCPM
Immune cell
- eosinophil: 25 nTPM
- myeloid DC: 22 nTPM
- intermediate monocyte: 22 nTPM
- NK-cell: 21 nTPM
- MAIT T-cell: 21 nTPM
- non-classical monocyte: 19 nTPM
Brain region
- cerebral cortex: 86 nTPM
- thalamus: 86 nTPM
- white matter: 82 nTPM
- basal ganglia: 79 nTPM
- amygdala: 78 nTPM
- hippocampal formation: 75 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin modification
- positive regulation of DNA-templated transcription
- positive regulation of muscle cell differentiation
- positive regulation of transcription by RNA polymerase II
- peptidyl-histidine methylation
- regulation of uterine smooth muscle contraction
Molecular functions
- actin binding
- histone H3K36 methyltransferase activity
- histone H3K4 methyltransferase activity
- protein-L-histidine N-tele-methyltransferase activity
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Rubisco LSMT, substrate-binding domain
- Rubisco LSMT, substrate-binding domain superfamily
- SET domain superfamily
- SETD3/SETD6 methyltransferase
- SET domain
- Rubisco LSMT substrate-binding
- Actin-histidine N-methyltransferase SETD3
- SETD3, SET domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SETD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SETD3 as an antibody target. Whether an autoantibody or antibody against SETD3 could matter depends on whether native SETD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SETD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SETD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...